Vadadustat for anemia relief in peritoneal dialysis patients
Treatments studied
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial tests whether a new medication called vadadustat can help dialysis patients manage anemia (low red blood cells), improve their quality of life, and reduce inflammation. You would take this medication alongside your current dialysis treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You receive peritoneal dialysis (a home dialysis method) as your regular kidney treatment
- You are a patient at MacKay Memorial Hospital's outpatient clinics
- You are currently taking darbepoetin alfa (a medication to treat anemia)
- Your blood pressure is 170/80 mmHg or lower (measured on at least three separate visits)
- You have not had a heart attack, stroke, or serious bleeding in your stomach or intestines in the past 3 months, and you do not have active cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an intravenous iron medication (iron isomaltoside) can improve anemia in patients on peritoneal dialysis. It may help those whose iron levels are low despite stable use of other anemia treatments.
This study tests roxadustat, a medicine that helps the body make more red blood cells, in children and teens with anemia caused by chronic kidney disease. It may help improve anemia and related blood counts, while also monitoring safety.
This trial tests whether taking an oral pill three times a week (vadadustat) works as well as injections (Epogen) to treat anemia—low red blood cells—in people on dialysis. If it works, a pill might be easier and more convenient than injections.
This trial tests a new oral medication (QLG1218, also called daprodustat) to treat anemia in people with chronic kidney disease who are on hemodialysis. It is comparing the new drug to the usual injected ESA medicines to see if it works as well or better.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
This study is testing a new way to manage anemia (low red blood cells) in people on long-term dialysis. It aims to improve how doctors treat this common issue.
Hear when a new Renal Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.